ARIAD Pharmaceuticals (ARIA) Announces Disappointing Ruling Regarding NF-(kappa)B Patent Lawsuit with Amgen (AMGN)
Tweet Send to a Friend
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced that the U.S. District Court for the District of Delaware granted Amgen's (Nasdaq ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
